OCGN FY 2022 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

$2M100.0% margin

Operating Income

-$89M-3580.0% margin

Net Income

-$87M-3488.9% margin

EPS (Diluted)

$-0.40

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$65M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$109M

Total Liabilities

$35M

Stockholders' Equity

$74M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$2M	$0	—
Operating Income	-$89M	-$58M	-53.5%
Net Income	-$87M	-$58M	-48.7%